Upper abdominal cytoreduction and thoracoscopy for advanced epithelial ovarian cancer: Unanswered questions and the impact on treatment

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 2, 2012, Pages 202-206

  Fleury, A C ^a   Kushnir, C L ^a   Giuntoli, R L ^a   Spirtos, N M ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Women's Cancer Center of Nevada   (United States)

Author keywords

Cytoreduction; diaphragm; ovarian cancer; splenectomy; thoracocscopy

Indexed keywords

ANTINEOPLASTIC AGENT;

ABSCESS; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CHYLOUS ASCITES; DIAPHRAGM; DIGESTIVE SYSTEM FISTULA; DISEASE SEVERITY; EPITHELIAL OVARIAN CANCER; HUMAN; LUNG EMBOLISM; OVARY CANCER; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; THORACOSCOPY; UPPER ABDOMINAL CYTOREDUCTION; URINARY TRACT FISTULA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, PARENTERAL; LENGTH OF STAY; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; THORACOSCOPY; TREATMENT OUTCOME;

EID: 83655167062     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.03197.x     Document Type: Article

References (22)

1. American Cancer Society. (2010). Cancer facts and figures 2010. []. Accessed 19 July 2011.
2. American Cancer Society. Cancer Facts and Figures 2011. Atlanta, GA: American Cancer Society, 2011.
3. Jemal A, Bray F, Cener MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
4. Hartge P, Whittemore AS, Itnyre J, McGowan L, Cramer D,. Rates and risks of ovarian cancer in subgroups of white women in the United States. The Collaborative Ovarian Cancer Group. Obstet Gynecol 1994; 84: 760-4. (Pubitemid 24329840)
5. Jhamb N, Lambrou N,. Epidemiology and clinical presentation of ovarian cancer. In:, Bristow RE, Armstrong DK, editors. Early Diagnosis and Treatment of Cancer, 1st edn. Philadelphia: Saunders Elsevier, 2010, pp. 1-15.
6. Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, et al., Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003; 21: 3194-200. (Pubitemid 46606249)
7. Markman M, Bundy BN, Alberts DS, Fowler JM, Clarke-Pearson DL, Carson LF, et al., Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 2001; 19: 1001-7. (Pubitemid 32176274)
8. Armstrong D, Bundy B, Wenzel L, Huang H, Baergen R, Lele S, et al., Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354: 34-43. (Pubitemid 43048949)
9. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY,. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 1999; 72: 278-87. (Pubitemid 29118182)
10. Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S,. Relative influence of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003; 90: 390-6. (Pubitemid 36952033)
11. Vergote I, Trope CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al., Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 2010; 363: 943-53.
12. Walker JL, Armstrong DK, Huang HQ, Fowler J, Webster K, Burger RA, et al., Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. Gynecol Oncol 2006; 100: 27-32. (Pubitemid 41815045)
13. Terauchi F, Kobayashi Y, Nagashima T, Moritake T, Nishi H, Fujito A, et al., Pilot study on transdiaphragmatic thoracoscopic-assisted pleural biopsy and intrathoracic washing cytology for Stage IIIc ovarian cancer with diaphragmatic metastases. Int J Gynecol Cancer 2009; 19: 300-3.
14. Spirtos NM, Kushnir CL, Eisenkop SM,. Upper abdominal cytoreduction: including diaphragm resection, splenectomy, distal pancreatectomy, and thoracoscopy. In:, Smith JR, Del Priore G, et al., editors. An Atlas of Gynecologic Oncology: Investigation and Surgery, 3rd edn. New York, NY: Informa Healthcare, 2011, pp. 160-8.
15. Eisenkop SM, Spirtos NM,. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol Oncol 2001; 82: 489-97. (Pubitemid 32826449)
16. Eisenkop SM,. Thoracoscopy for the management of advanced epithelial ovarian cancer-a preliminary report. Gynecol Oncol 2002; 84: 315-20. (Pubitemid 34136786)
17. Chi DS, Abu-Rustum N, Sonoda Y, Chen SW, Flores DM, Downey R, et al., The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusion. Gynecol Oncol 2004; 94: 307-11. (Pubitemid 39024531)
18. Juretzka MM, Abu-Rustum NR, Sonoda Y, Downey RJ, Flores RM, Park BJ, et al., The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusion. Gynecol Oncol 2007; 104: 670-4. (Pubitemid 46240259)
19. Cohen-Mouly S, Badia A, Bats AS, Barthes F, Bensaud S, Riquet M, et al., Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion. Int J Gynecol Cancer 2009; 19: 1662-5.
20. Lim MC, Lee H, Jung DC, Choi JY, Seo SS, Park SY,. Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery. Ann Surg Oncol 2009; 16: 1990-6.
21. Eisenkop SM, Spirtos NM,. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival? Gynecol Oncol 2001; 82: 435-41. (Pubitemid 32826441)
22. Aletti GD, Dowdy SC, Podratz KC, Cliby WA,. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 2006; 100: 283-7. (Pubitemid 43078481)